Bloomberg Anywhere Remote Login Bloomberg Terminal Demo Request


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

Last ¥949.00 JPY
Change Today +5.00 / 0.53%
Volume 533.0K
4403 On Other Exchanges
As of 1:00 AM 11/30/15 All times are local (Market data is delayed by at least 15 minutes).

nof corp (4403) Snapshot

Previous Close
Day High
Day Low
52 Week High
08/11/15 - ¥1,099
52 Week Low
12/16/14 - ¥718.00
Market Cap
Average Volume 10 Days
Shares Outstanding
Dividend Yield
Current Stock Chart for NOF CORP (4403)

Related News

No related news articles were found.

nof corp (4403) Related Businessweek News

No Related Businessweek News Found

nof corp (4403) Details

NOF Corporation engages in the oleo and specialty chemicals business worldwide. The company operates in four segments: Functional Chemicals, Life Science, Explosive & Propulsion, and Others. It offers fatty acids and glycerin, fatty acid derivatives, and surfactants, as well as petrochemical products; and functional chemicals and polymers, such as organic peroxides, petrochemicals, and functional polymers. The company also provides industrial explosives comprising tunnel construction supplying dynamites, emulsion explosives, electric detonator caps, remote control blasting systems, and other products; explosives for defense and space use; and consumer products, including automotive safety components, temperature indicating materials, sterilization materials, pharmaceutical materials, and crime prevention devices. In addition, it offers edible oils, such as margarine, shortening, confectionary oils, depanning oils, fillings and toppings, oil and fat powders, and ingredients for processed foods; and health-related products that comprise functional lipids, nano-emulsion products, micro-encapsulated products, and enteral nutritional products. Further, the company develops life science products, such as MPC biocompatible materials; and diagnostic and research-use reagents comprising antibodies for various antigens, as well as produces activated PEGs and PEGlyation, phospholipids, and unsaturated fatty acids and their derivatives. Additionally, it provides functional films, including anti-reflection film ReaLook, anti-finger mark film ClearTouch and PenFit, and matching film LightNavi for the use in tablets and Smartphones. The company also supplies anti-corrosion treatment systems; dry galvanizing treatment products; and sealers. In addition, it is involved in truck transportation, freight handling, insurance agency, and real estate businesses. The company was founded in 1937 and is headquartered in Tokyo, Japan.

3,791 Employees
Last Reported Date: 06/26/15
Founded in 1937

nof corp (4403) Top Compensated Officers

No compensation data is available at this time for the top officers at this company.

Executives, Board Directors

nof corp (4403) Key Developments

NOF Corporation to Report Q2, 2016 Results on Nov 05, 2015

NOF Corporation announced that they will report Q2, 2016 results on Nov 05, 2015

NOF Corporation Reports Audited Consolidated Earnings Results for the Year Ended March 31, 2015

NOF Corporation reported audited consolidated earnings results for the year ended March 31, 2015. For the period, the company reported net sales of ¥167,698 million compared with ¥160,963 million for the same period last year. Income before income taxes and minority interests was of ¥17,681 million compared with ¥14,756 million for the same period last year. Net income was of ¥11,704 million compared with ¥9,738 million for the same period last year. Net cash provided by operating activities was ¥14,231 million compared with ¥15,692 million for the same period last year. Payments for purchase of property, plant and equipment was ¥8,034 million compared with ¥6,807 million for the same period last year.

NOF Corporation to Report Q1, 2016 Results on Aug 04, 2015

NOF Corporation announced that they will report Q1, 2016 results on Aug 04, 2015


Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
4403:JP ¥949.00 JPY +5.00

4403 Competitors

Market data is delayed at least 15 minutes.

Company Last Change
Abzena PLC 63.50 GBp 0.00
Dr Reddy's Laboratories Ltd 3,108 INR +8.50
Enzon Pharmaceuticals Inc $0.73 USD +0.01
Nektar Therapeutics $15.42 USD +0.21
Novo Nordisk A/S kr388.30 DKK +2.30
View Industry Companies

Industry Analysis


Industry Average

Valuation 4403 Industry Range
Price/Earnings 12.6x
Price/Sales 1.0x
Price/Book 1.2x
Price/Cash Flow 12.4x
TEV/Sales 0.8x

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact NOF CORP, please visit Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at